EMBOTRAP III
- Risk class
- IV
- Product type
- Invasive
- Brand name
- CERENOVUS EMBOTRAP™ III
- Commercial name
- Stents, Vascular
- Analysis ID
- 5bdb2140a0dfb7ae67099a39c6509f11
- Registration date
- August 26, 2021
- Expiration date
- August 26, 2026
- Country
- IRELAND
- Address
- PARKMORE BUSINESS PARK WEST
- Name
- NEURAVI LIMITED
- Country
- IRELAND
- Address
- AV. CORUÑA N28-14 Y MANUEL ITURREY, EDIFICIO SANTA FE, OF 11, DIAGONAL A DOMINOS PIZZA
- Phone
- 983350955
DESIGNED FOR USE IN THE ANTERIOR AND POSTERIOR NEUROVASCULATURE IN BLOOD VESSELS, SUCH AS THE INTERNAL CAROTID ARTERY, THE M1 AND M2 SEGMENTS OF THE MIDDLE CEREBRAL ARTERY, THE A1 AND A2 SEGMENTS OF THE ANTERIOR CEREBRAL ARTERY, THE BASILAR ARTERY, THE POSTERIOR CEREBRAL ARTERY, AND THE VERTEBRAL ARTERIES.
Access comprehensive regulatory information for EMBOTRAP III in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 5bdb2140a0dfb7ae67099a39c6509f11 and manufactured by ADVANT MEDICAL LTD.. The device was registered on August 26, 2021.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.